Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
出版年份 2020 全文链接
标题
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial
作者
关键词
-
出版物
THROMBOSIS AND HAEMOSTASIS
Volume -, Issue -, Pages -
出版商
Georg Thieme Verlag KG
发表日期
2020-09-14
DOI
10.1055/s-0040-1716540
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
- (2020) Ashley Chen et al. Journal of the American Heart Association
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of body mass index on the safety and effectiveness of direct oral anticoagulants: a retrospective review
- (2019) Jared Netley et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
- (2019) Margarita Kushnir et al. Lancet Haematology
- Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight
- (2019) Stefan H. Hohnloser et al. CIRCULATION
- Efficacy and Safety of Edoxaban Compared to Warfarin According to the Burden of Diseases in Patients with Atrial Fibrillation: Insights from the ENGAGE AF-TIMI 48
- (2019) André M Nicolau et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial
- (2018) Ophelia Q. P. Yin et al. CIRCULATION
- Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
- (2018) Bianca Rocca et al. EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Use of the SAMe-TT 2 R 2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review
- (2018) Hanis Zulkifly et al. HEART RHYTHM
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
- (2018) Giuseppe Boriani et al. EUROPEAN HEART JOURNAL
- North American Thrombosis Forum, AF Action Initiative Consensus Document
- (2016) Christian T. Ruff et al. AMERICAN JOURNAL OF MEDICINE
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
- (2016) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
- (2016) K. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
- (2015) Giuseppe Boriani et al. EUROPACE
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
- (2015) Christian T Ruff et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
- (2011) H. Quan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now